SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-313813
Filing Date
2018-10-31
Accepted
2018-10-31 15:36:03
Documents
3
Period of Report
2018-10-31

Document Format Files

Seq Description Document Type Size
1 6-K d551584d6k.htm 6-K 9379
2 EX-99.1 d551584dex991.htm EX-99.1 13787
3 GRAPHIC g551584g50m86.jpg GRAPHIC 7122
  Complete submission text file 0001193125-18-313813.txt   34088
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38079 | Film No.: 181150108
SIC: 2834 Pharmaceutical Preparations